Clinical Trial

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Study acronym: Tigris
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This trial is a randomized study to evaluate and compare two doses of the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-01; most recent amendment 2025-08-21.
Status change: Recruiting → Active, Not Recruiting 2024-10-08
Trial Details
NCT Number NCT06120842
Lead Sponsor SpyGlass Pharma, Inc.
Conditions Cataract, Glaucoma, Ocular Hypertension
Enrollment 201 participants
Start Date 2023-10-13
Primary Completion 2025-01-31 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-22